REPLIMUNE LTD has a total of 47 patent applications. It decreased the IP activity by 53.0%. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and pharmaceuticals are 4D MOLECULAR THERAPEUTICS INC, HOBDEN ADRIAN and ALEX LEVITZKI MAN AND HOLDINGS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 5 | |
#5 | China | 4 | |
#6 | United Kingdom | 4 | |
#7 | Hong Kong | 3 | |
#8 | Australia | 2 | |
#9 | Brazil | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Israel | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Coffin Robert | 26 |
#2 | Coffin Robert Stuart | 10 |
#3 | Robert Stuart Coffin | 3 |
#4 | Robert Coffin | 2 |
#5 | Coffin Robert S | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019243847A1 | Treatment using oncolytic virus | |
EP3400292A1 | Use of an oncolytic virus for the treatment of cancer | |
GB201700350D0 | Altered virus | |
GB201600380D0 | Modified virus | |
GB201600381D0 | Virus strain | |
GB201600382D0 | Engineered virus |